All terms in HP

Label Id Description
Osteolysis involving bones of the upper limbs HP_0045039
Reduced muscle enolase activity HP_0034633 [Diminished activity of the enzyme enolase in muscle tissue. The enzyme enolase catalyzes the interconversion of 2-phosphoglycerate and phosphoenolpyruvate. In adult human muscle, over 90% of enolase activity is accounted for by the beta-enolase subunit, the protein product of the ENO3 gene.]
Low alkaline phosphatase of renal origin HP_0010685 [An abnormally reduced level of kidney isoforms of alkaline phosphatase in the blood.]
Dopamine antagonist exposure HP_0034634 [History of having been treated with a dopamine antagonist including metaclopramide, phenothiazine; haloperidol, chlorpromazine, promethazine, prochlorperazine, ziprasidone, and quetiapine.]
negative regulation of biological process GO_0048519 [Any process that stops, prevents, or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.]
positive regulation of biological process GO_0048518 [Any process that activates or increases the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.]
spermatid differentiation GO_0048515 [The process whose specific outcome is the progression of a spermatid over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.]
all-cis-docosa-7,10,13,16-tetraenoic acid CHEBI_53487 [The all-cis-isomer of a C22 polyunsaturated fatty acid having four double bonds in the 7-, 10-, 13- and 16-positions. One of the most abundant fatty acids in the early human brain.]
docosatetraenoic acid CHEBI_61205 [Any straight-chain, C22 fatty acid having four C=C double bonds.]
omega-6 fatty acid CHEBI_36009 [A family of polyunsaturated fatty acids that have in common a final carbon-carbon double bond in the n-6 position, i.e., the sixth bond from the methyl end of the fatty acid.]
3-D extent PATO_0001710 [A size quality inhering in an bearer by virtue of the bearer's extension in three dimensions.]
decreased rate PATO_0000911 [A rate which is relatively low.]
increased rate PATO_0000912 [A rate which is relatively high.]
EC 6.4.1.1 (pyruvate carboxylase) inhibitor CHEBI_90318 [An EC 6.4.1.* (carboxylase) inhibitor that interferes with the action of pyruvate carboxylase (EC 6.4.1.1).]
EC 6.4.1.* (carboxylase) inhibitor CHEBI_76824 [An EC 6.4.* (C-C bond-forming ligase) inhibitor that interferes with the action of a carboxylating enzyme (EC 6.4.1.*).]
renal lobule UBERON_0009914 [The portion of a renal lobe consisting of nephrons grouped around a single medullary ray and draining into a single collecting duct; human kidneys have multilobular, multipapillary architecture while mice and rats have unilobular, unipapillary kidneys.]
renal lobe UBERON_0009913 [The portion of a kidney consisting of a renal medullary pyramid and the renal cortex above it[MP]. It is composed of many renal lobules[WP].]
positive regulation of behavior GO_0048520 [Any process that activates or increases the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.]
regulation of behavior GO_0050795 [Any process that modulates the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.]
negative regulation of behavior GO_0048521 [Any process that stops, prevents, or reduces the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.]